Multiomic Analyses Identify New Pneumonia Biomarkers
BGI Genomics
Some nine sets of metagenomic and transcriptomic biomarkers outperformed existing clinical prediction models
The model analyzes methylation changes in the cell-free DNA of pregnant women at risk of preeclampsia
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers